Literature DB >> 9824854

Glycemic index, nutrient density, and promotion of aberrant crypt foci in rat colon.

D E Corpet1, G Peiffer, S Taché.   

Abstract

We speculated that a diet with a high glycemic index (GI) or a diet with a low nutrient density (nutrient-to-calorie ratio) would enhance colon carcinogenesis, presumably via increased insulin resistance. Forty-eight Sprague-Dawley (SD) rats received an azoxymethane injection (20 mg/kg) and were randomized into five groups given an AIN-76 diet containing 1) 65% starch by weight, 2) 65% glucose (GI = 100), 3) 65% fructose (GI = 23), 4) 82% starch, or 5) 39% oil and 39% sucrose. The nutrient density of Diets 4 and 5 was one-half that of Diets 1-3. Promotion was assessed by the multiplicity (number of crypts) of aberrant crypt foci (ACF), an early marker of colon carcinogenesis. Insulin resistance was estimated by the FIRI index (blood insulin x blood glucose), by plasma triglycerides, and by visceral fat. To confirm the results in another rat strain, the experiment was duplicated in 48 Fischer (F344) rats. Results show that 1) the ACF multiplicity was not different in glucose- and fructose-fed rats (p > 0.7): diets with contrasting GI had the same effect on ACF growth; 2) diets of low nutrient density increased visceral fat (p < 0.05) but reduced the ACF size in F344 rats (p < 0.001, no reduction in SD rats); and 3) indirect insulin resistance markers (FIRI index, blood triglycerides, and visceral fat) did not correlate with ACF multiplicity. These results do not support the hypothesis that diets with a high GI or low nutrient density or diets that increase some indirect insulin resistance markers can promote colon carcinogenesis in F344 or SD rats.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9824854      PMCID: PMC2566797          DOI: 10.1080/01635589809514713

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  48 in total

Review 1.  International tables of glycemic index.

Authors:  K Foster-Powell; J B Miller
Journal:  Am J Clin Nutr       Date:  1995-10       Impact factor: 7.045

2.  Physiological modulation of plasma free fatty acid concentrations by diet. Metabolic implications in nondiabetic subjects.

Authors:  T M Wolever; A Bentum-Williams; D J Jenkins
Journal:  Diabetes Care       Date:  1995-07       Impact factor: 19.112

3.  A simple measure of insulin resistance.

Authors:  M H Duncan; B M Singh; P H Wise; G Carter; J Alaghband-Zadeh
Journal:  Lancet       Date:  1995-07-08       Impact factor: 79.321

4.  Plasma plasminogen activator inhibitor activity in rats with nutritionally induced insulin resistance.

Authors:  V Scelles; M C Alessi; D Raccah; I Juhan-Vague; P Vague
Journal:  Thromb Haemost       Date:  1995-08       Impact factor: 5.249

Review 5.  Dietary sugars and lipid metabolism in humans.

Authors:  K N Frayn; S M Kingman
Journal:  Am J Clin Nutr       Date:  1995-07       Impact factor: 7.045

Review 6.  Risk factors for colon neoplasia--epidemiology and biology.

Authors:  J D Potter
Journal:  Eur J Cancer       Date:  1995 Jul-Aug       Impact factor: 9.162

7.  Fructose-induced hypertension in rats is concentration- and duration-dependent.

Authors:  S Dai; J H McNeill
Journal:  J Pharmacol Toxicol Methods       Date:  1995-04       Impact factor: 1.950

8.  Development of insulin resistance in the rat is dependent on the rate of glucose absorption from the diet.

Authors:  J A Higgins; J C Brand Miller; G S Denyer
Journal:  J Nutr       Date:  1996-03       Impact factor: 4.798

9.  VLDL triglyceride kinetics in Wistar fatty rats, an animal model of NIDDM: effects of dietary fructose alone or in combination with pioglitazone.

Authors:  T Kazumi; T Hirano; H Odaka; T Ebara; N Amano; T Hozumi; Y Ishida; G Yoshino
Journal:  Diabetes       Date:  1996-06       Impact factor: 9.461

Review 10.  Insulin and colon cancer.

Authors:  E Giovannucci
Journal:  Cancer Causes Control       Date:  1995-03       Impact factor: 2.506

View more
  1 in total

1.  Number of aberrant crypt foci associated with adiposity and IGF1 bioavailability.

Authors:  Helen Swede; Thomas E Rohan; Herbert Yu; Joseph C Anderson; Richard G Stevens; Jane Brokaw; Joel Levine; Bruce M Brenner; Carl D Malchoff; Valerie B Duffy; Devon C Pleau; Daniel W Rosenberg
Journal:  Cancer Causes Control       Date:  2008-12-09       Impact factor: 2.506

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.